cpx
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 1997 (NCT00004428)
Timeline
1990s
- Jan 1, 1997
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- A1 adenosine receptorINHIBITOR
A1 adenosine receptor inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 1,3-dipropyl-8-cyclopentylxanthine
- 1,3-dpcpx
- 8-cyclopentyl-1,3-dipropylxanthine
- 8-cyclopentyl-1,3-dipropylxanthine
- 8-cyclopentyl-1,3-dipropylxanthine
- 8-cyclopentyl-3,7-dihydro-1,3-dipropyl-1h-purin-2,6-dione
- cpx
- cpx
- cpx
- dpcpx
- pd 116948
- pd-116,948
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00004428 | Phase 1 | Sep 1, 1997 | Food and Drug Administration, SciClone Pharmaceuticals |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Food and Drug Administration | Government | 1 | 1 | 1 | 1997 |
| SciClone Pharmaceuticals | For profit | 1 | 0 | 1 | 1997 |
2 organizations
Page 1 / 1